Rare Rh genotype identified in pregnant woman in India
An RhD-negative mother with alloimmunization and an uncommon Rh genotype delivered a healthy child with no evidence of HDFN.
An RhD-negative mother with alloimmunization and an uncommon Rh genotype delivered a healthy child with no evidence of HDFN.
The rosette test, Kleihauer–Betke test and flow cytometry are the three most common tools for diagnosing fetomaternal hemorrhage in Canada.
A study found that complete blood counts may be used to diagnose placental abruption, a risk factor for HDFN with no diagnostic tests.
Researchers conducted a nationwide survey to better understand patient-reported trends in treatment and outcomes for HDFN.
A recent study represents the first publication documenting cases of severe HDFN in Slovenia, with overall positive outcomes reported.
Ambient light exposure may cause results of a test for neonatal jaundice, a complication of HDFN, to be inaccurate.
Next-generation sequencing is a highly precise tool that may be used to identify pregnancies at risk of HDFN, a recent study found.
A recent literature review found that cell-free DNA analysis may be a safe and reliable method of identifying pregnancies at risk of HDFN.
Gel microcolumn assay (GMA) effectively identifies pregnancies at high risk for severe HDFN, but its false positivity rate remains high.
A recent study found that an anti-Kell antibody level of eight can be used to reliably identify patients at risk of severe HDFN.